Atterocor Receives $16,000,000 Series A Financing Round
Company Name Atterocor
Mailing Address 820 Heatherway Ann Arbor, MI 48104
Company Description Atterocor is an innovative company focused on the accelerated development of a treatment for adrenal cancer. Founded in 2012 and backed by top-tier life sciences investors, Atterocor is based in Ann Arbor, Michigan.